Locally advanced breast cancer in octogenarian women

被引:7
作者
Mano, M [1 ]
Fraser, G [1 ]
McIlroy, P [1 ]
Stirling, L [1 ]
MacKay, H [1 ]
Ritchie, D [1 ]
Canney, P [1 ]
机构
[1] Western Infirm & Associated Hosp, Beatson Oncol Ctr, Glasgow G11 6NT, Lanark, Scotland
关键词
elderly patients; locally advanced breast cancer; primary chemotherapy; primary hormonal therapy; primary radiotherapy;
D O I
10.1007/s10549-004-1003-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Elderly patients are more likely to present with locally advanced breast cancer than younger patients. Furthermore, due to the accelerated aging of the western population, the incidence of breast cancer in this population is expected to steadily rise in the coming decades. So far, no guidelines are available for the management of octogenarian patients presenting with inoperable disease, what frequently results in a dilemma for the treating physician. For the time being, these patients should be ideally treated within the context of a clinical trial. In all other cases, the treatment has to be individualised, frequently based on data extrapolated from different population of patients, or retrospective series. This article reviews the current evidence, options, and most promising approaches for these patients.
引用
收藏
页码:81 / 90
页数:10
相关论文
共 110 条
[1]   Primary systemic treatment with weekly doxorubicin monotherapy in women with locally advanced breast cancer; Clinical experience and parameters predicting outcome [J].
Aas, T ;
Geisler, S ;
Paulsen, T ;
BorresenDale, AL ;
Varhaug, JE ;
Lonning, PE ;
Akslen, LA .
ACTA ONCOLOGICA, 1996, 35 (05) :5-8
[2]   Does induction chemotherapy with a mitoxantrone/vinorelbine regimen allow a breast-conservative treatment in patients with operable locoregional breast cancer? A French Northern Oncology Group trial in 105 patients [J].
Adenis, A ;
Vanlemmens, L ;
Fournier, C ;
Hecquet, B ;
Bonneterre, J .
BREAST CANCER RESEARCH AND TREATMENT, 1996, 40 (02) :161-169
[3]  
Allred DC, 1998, MODERN PATHOL, V11, P155
[4]   A PHASE-III RANDOMIZED TRIAL OC CYCLOPHOSPHAMIDE, MITOXANTRONE, AND 5-FLUOROURACIL (CNF) VERSUS CYCLOPHOSPHAMIDE, ADRIAMYCIN, AND 5-FLUOROURACIL (CAF) IN PATIENTS WITH METASTATIC BREAST-CANCER [J].
ALONSO, MC ;
TABERNERO, JM ;
OJEDA, B ;
LLANOS, M ;
SOLA, C ;
CLIMENT, MA ;
SEGUI, MA ;
LOPEZ, JJ .
BREAST CANCER RESEARCH AND TREATMENT, 1995, 34 (01) :15-24
[5]  
ALUND M, 1977, SURG GYNECOL OBSTET, V144, P235
[6]  
Balducci L, 2001, Cancer Control, V8, P431
[7]  
Balducci L, 2001, CURR PROB CANCER, V25, P7
[8]   A WEEKLY SCHEDULE OF EPIRUBICIN IN PRETREATED ADVANCED BREAST-CANCER [J].
BARNI, S ;
ARCHILI, C ;
LISSONI, P ;
PAOLOROSSI, F ;
CRISPINO, S ;
TANCINI, G .
TUMORI, 1993, 79 (01) :45-48
[9]   PROSPECTIVE CLINICAL TRIAL OF POSTOPERATIVE RADIOTHERAPY DELIVERED IN 3 FRACTIONS PER WEEK VERSUS 2 FRACTIONS PER WEEK IN BREAST CARCINOMA [J].
BATES, TD .
CLINICAL RADIOLOGY, 1975, 26 (03) :297-304
[10]   Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer [J].
Batist, G ;
Ramakrishnan, G ;
Rao, CS ;
Chandrasekharan, A ;
Gutheil, J ;
Guthrie, T ;
Shah, P ;
Khojasteh, A ;
Nair, MK ;
Hoelzer, K ;
Tkaczuk, K ;
Park, YC ;
Lee, LW .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) :1444-1454